Etiology and Early Diagnosis of Neurodevelopmental Disorders
1 other identifier
observational
576
1 country
1
Brief Summary
The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 25, 2013
CompletedFirst Posted
Study publicly available on registry
December 6, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 6, 2024
CompletedJuly 8, 2024
July 1, 2024
12.1 years
November 25, 2013
July 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medical abnormalities associated with specific neurodevelopmental disorders
It is unknown if a specific set of biological abnormalities contribute to the formation of many types of neurodevelopmental disorders. The study is intended to identify the relationship between biological abnormalities and neurodevelopmental disorders
up to 7 years
Secondary Outcomes (2)
Biomarkers associated with neurodevelopmental disorders
up to 7 years
Treatments associated with neurodevelopmental disorders
up to 7 years
Study Arms (1)
Neurodevelopmental Disorders
Children who present to various Arkansas Children's Hospital clinics for standard care related to neurodevelopmental disorders.
Eligibility Criteria
Children who present to various Arkansas Children's Hospital Outpatient clinics for standard care related to neurodevelopmental disorders.
You may qualify if:
- Neurodevelopmental delays
- Clinical visit at an Arkansas Children's Hospital Outpatient clinic
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arkansas Children's Hospital Research Institute
Little Rock, Arkansas, 72205, United States
Related Publications (1)
Frye RE, Lionnard L, Singh I, Karim MA, Chajra H, Frechet M, Kissa K, Racine V, Ammanamanchi A, McCarty PJ, Delhey L, Tippett M, Rose S, Aouacheria A. Mitochondrial morphology is associated with respiratory chain uncoupling in autism spectrum disorder. Transl Psychiatry. 2021 Oct 13;11(1):527. doi: 10.1038/s41398-021-01647-6.
PMID: 34645790DERIVED
Related Links
Biospecimen
Blood, urine, cerebrospinal fluid, muscle, and skin samples may be retained.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shannon Rose, PhD.
Arkansas Children's Hospital Research Instisute; UAMS
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 25, 2013
First Posted
December 6, 2013
Study Start
May 1, 2012
Primary Completion
June 6, 2024
Study Completion
June 6, 2024
Last Updated
July 8, 2024
Record last verified: 2024-07